Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

2000 • 8,612 citations

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

1999 • 8,588 citations

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

2003 • 4,640 citations

Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated

1988 • 1,607 citations

Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure

1999 • 898 citations

EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION

2003 • 736 citations

Spironolactone Increases Nitric Oxide Bioactivity, Improves Endothelial Vasodilator Dysfunction, and Suppresses Vascular Angiotensin I/Angiotensin II Conversion in Patients With Chronic Heart Failure

2000 • 525 citations

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

1997 • 342 citations

Mineralocorticoid Receptor Antagonism in Experimental Atherosclerosis

2002 • 220 citations

Effects of Long-Term Monotherapy With Eplerenone, a Novel Aldosterone Blocker, on Progression of Left Ventricular Dysfunction and Remodeling in Dogs With Heart Failure

2002 • 217 citations

Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-κB Activation in Angiotensin II–Induced Cardiac Injury

2001 • 208 citations

Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology

2000 • 198 citations

Synergistic Effect of Adrenal Steroids and Angiotensin II on Plasminogen Activator Inhibitor-1 Production1

2000 • 183 citations

Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure

2001 • 159 citations

Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction

2002 • 153 citations

VASCULAR TYPE I ALDOSTERONE BINDING SITES ARE PHYSIOLOGICAL MINERALOCORTICOID RECEPTORS

1989 • 139 citations

The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure

2002 • 132 citations

Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction

2001 • 97 citations

Endothelial Cell Dysfunction in Mice After Transgenic Knockout of Type 2, but Not Type 1, 11β-Hydroxysteroid Dehydrogenase

2001 • 77 citations

Synergistic Effect of Adrenal Steroids and Angiotensin II on Plasminogen Activator Inhibitor-1 Production

2000 • 62 citations

11β-Hydroxysteroid Dehydrogenase in Cultured Human Vascular Cells

1999 • 54 citations

Identification and role of aldosterone receptors in the cardiovascular system.

2000 • 41 citations

Efficacy and safety of eplerenone, enalapril, and eplerenone/enalapril combination therapy in patients with left ventricular hypertrophy

2002 • 29 citations